Herb and medicine interaction

Ashwagandha and antidepressants (SSRIs, SNRIs)

Ashwagandha (asgandh) (Withania somnifera) with SSRI and SNRI antidepressants such as sertraline, escitalopram, fluoxetine, duloxetine and venlafaxine.

Evidence of interactionPending medical review

The short answer

Possibly. Doctors in Kraków, Poland, reviewed adverse-event reports and found a few that they judged were probably caused by ashwagandha taken with an antidepressant. These included severe diarrhoea with sertraline, nausea, vomiting and muscle pain with escitalopram, and muscle and eye pain with paroxetine.

These are single reports, and they cannot show how often this happens. A small trial in Iran gave ashwagandha to people already on SSRIs and recorded no side effects, but it lasted only six weeks. If you take an SSRI or SNRI, tell your prescribing doctor before you start ashwagandha, and report any new stomach, muscle or eye symptoms.

Sold in India as Nexito (escitalopram), Fludac (fluoxetine), Duzela (duloxetine) and Venlor (venlafaxine).

At a glance

What was seenHow it may workDirectionEvidence
Side effects judged to be caused by ashwagandha with sertraline, escitalopram or paroxetine[1]Not establishedStomach, muscle and eye side effectsCase report
Narrowing of brain blood vessels in a woman using ashwagandha, medical marijuana and an SNRI[2]Not established; several exposuresReversible cerebral vasoconstriction syndrome, which resolvedCase report
Ashwagandha added to SSRIs improved OCD scores, with no side effects reported[3]Not establishedNo harm seen in six weeks; too small to find rare problemsRCT
No reversible blocking of liver enzymes by root or leaf extracts[4]No CYP inhibition at the strengths testedDoes not rule out other routesIn vitro
Liver injury from ashwagandha products[5]Not establishedHerb safety context, not an interactionCase report

No listing is not a clearance. A missing interaction here never means a combination is safe.

The evidence, study by study

Review of adverse-event reports, Poland, 2023 Case report

Doctors in Kraków reviewed 1,816 adverse-event reports and found 30 that were probably caused by an adaptogen herb taken with an antidepressant. The ashwagandha reports involved sertraline (severe diarrhoea), escitalopram (muscle pain, stomach pain, nausea, vomiting, restless legs and a severe cough) and paroxetine (widespread muscle pain, eye pain and raised eye pressure). One more involved reboxetine, another antidepressant. Reports like these cannot give a rate, and other medicines may have played a part.[1]

Case summarised by Memorial Sloan Kettering Case report

The cancer centre's herb monograph lists a 47-year-old woman who developed reversible cerebral vasoconstriction syndrome, a temporary narrowing of blood vessels in the brain. She had used ashwagandha, medical marijuana and an SNRI antidepressant. Her symptoms resolved with treatment. With three exposures, no single cause can be named.[2]

Trial in obsessive-compulsive disorder, Iran, 2016 RCT

At Mashhad University of Medical Sciences, 30 people with OCD who were all taking SSRIs added ashwagandha root extract (120 mg a day) or a placebo for six weeks. OCD scores fell further with ashwagandha (median change -8 against -2), and no side effects were reported. With 15 people on ashwagandha, the trial was far too small to pick up uncommon problems.[3]

Laboratory study, United States, 2025 In vitro

At Auburn University, four extracts of ashwagandha root and leaf were tested against seven liver enzymes that clear many medicines. None blocked them in a reversible way at the strengths tested. This does not cover enzyme induction or effects on the brain.[4]

Case series, India, 2023 Case report

Liver specialists at several Indian centres described 8 people with liver injury after single-herb ashwagandha products. Five already had chronic liver disease, and three of them developed acute-on-chronic liver failure and died. This is about ashwagandha's own risk to the liver, not about antidepressants.[5]

What your doctor may watch for

  • New diarrhoea, nausea or vomiting, muscle pain, or eye pain after starting ashwagandha.[1]
  • Yellow eyes or skin, dark urine or itching, which can be signs of liver injury.[5]

What to tell your prescribing doctor

You can read this out, or show them this page:

“I am taking, or planning to take, ashwagandha (name of product, form and how much) along with my antidepressant. Doctors have reported side effects with ashwagandha and sertraline, escitalopram or paroxetine. Is this combination a concern for me, and what should I watch for?”

Withheld until review

Dose adjustments and any “no known interaction” clearance appear only after a vaidya on our medical board has reviewed this page. Why we hold these back

Questions people ask

Can ashwagandha replace my antidepressant?

No study supports that. In the Iranian trial, ashwagandha was added to SSRIs, not used instead of them. Any change to an antidepressant is for your prescribing doctor to decide.[3]

Does it matter which antidepressant I take?

The reports we found involved sertraline, escitalopram and paroxetine, and one case involved an SNRI. Nobody has compared antidepressants for this, so the absence of a report for your medicine tells you nothing either way.[1][2]

Related

Sources

  1. Siwek M, Woroń J, Wrzosek A, Gupało J, Chrobak AA. Harder, better, faster, stronger? Retrospective chart review of adverse events of interactions between adaptogens and antidepressant drugs. Front Pharmacol. 2023;14:1271776. PMID 37829299.
  2. Memorial Sloan Kettering Cancer Center. About Herbs: Ashwagandha.
  3. Jahanbakhsh SP, Manteghi AA, Emami SA, Mahyari S, Gholampour B, Mohammadpour AH, Sahebkar A. Evaluation of the efficacy of Withania somnifera (ashwagandha) root extract in patients with obsessive-compulsive disorder: a randomized double-blind placebo-controlled trial. Complement Ther Med. 2016;27:25-29. PMID 27515872.
  4. Raichura Z, Heck K, Choi J, Yang L, Brandes M, Marney L, Mangaña AA, Neff C, Maier CS, Soumyanath A, van Breemen RB, Arnold RD, Calderón AI. Evaluation of reversible cytochrome P450 inhibition by Withania somnifera leaf and root extracts. Drug Metab Dispos. 2025;53(2):100024. PMID 40023576.
  5. Philips CA, Valsan A, Theruvath AH, Ravindran R, Oommen TT, Rajesh S, Bishnu S, Augustine P; Liver Research Club India. Ashwagandha-induced liver injury: a case series from India and literature review. Hepatol Commun. 2023;7(10):e0270. PMID 37756041.

Awaiting review by The Good Vaidya Medical Board. Prepared from the sources below and checked against each one.

Published 4 November 2026 · Last updated 4 November 2026

Taking ashwagandha with other medicines? A vaidya can check your full list.

Medicine Check · ₹299
Suggest a correctionChangelogHow we write these pagesNot a diagnosis or prescription. In an emergency, call 112.